The novel drug reduces the need for burdensome phlebotomy and also addresses fatigue, thereby improving quality of life for ...

Adding rusfertide to standard of care more than doubled the share of patients with polycythemia vera (PV) who did not meet ...

CHICAGO -- The use of the investigational weekly subcutaneous injection rusfertide significantly reduced the need for ...

Rusfertide could be a new treatment option for patients with polycythemia vera, according to Andrew Kuykendall, MD.

Panelists discuss how new treatments like rusfertide (a hepcidin mimetic) offer promising options for polycythemia vera patients, demonstrating benefits in reducing phlebotomy requirements while ...

Rusfertide (Protagonist Therapeutics/Takeda Pharmaceuticals) — administered as a once-weekly subcutaneous injection — also ...

Researchers at Stanford have developed a new technology for removing blood clots that is more than twice as effective as ...

The selection and design of blood collection tubes have emerged as critical factors in clinical chemistry, influencing both the integrity of analytes and the efficiency of laboratory workflows.

SEALmatic M is Lmb’s solution to create perfect tube segments and offer a maximum ... round out Sealmatic M as the perfect assistant in blood donation.

Scoda Tubes share allotment is likely to be declared today, June 2 on the official registrar of the company, Link Intime India Pvt Ltd. The Rs 220-crore issue got subscribed a whopping 53.78 times ...

The product contains hemoglobin molecules from expired donor blood, which are encapsulated in protective lipid shells.